David Ray Shalinsky

Title: David Ray Shalinsky: Innovator in Pharmaceutical Compositions

Introduction

David Ray Shalinsky is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target protein kinases. His work is essential in the fight against various diseases, including cancer.

Latest Patents

Shalinsky holds a patent for "Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use." This patent describes indazole compounds that modulate and inhibit the activity of specific protein kinases. These compounds are capable of mediating tyrosine kinase signal transduction, which can help in controlling unwanted cell proliferation. The invention also focuses on the therapeutic use of these pharmaceutical compositions in treating cancer and other conditions associated with unwanted angiogenesis and cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis.

Career Highlights

David Ray Shalinsky is associated with Agouron Pharmaceuticals, Inc., where he has been instrumental in advancing pharmaceutical research. His innovative approach has led to the development of effective treatments that address critical health issues.

Collaborations

Shalinsky has worked alongside talented colleagues, including Steven Lee Bender and Dana Dan Hu-Lowe. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical industry.

Conclusion

David Ray Shalinsky's work in developing indazole compounds represents a significant advancement in pharmaceutical science. His contributions are vital in the ongoing battle against diseases that affect millions worldwide.